A detailed history of Foundation Resource Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Foundation Resource Management Inc holds 207,739 shares of GILD stock, worth $18.7 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
207,739
Previous 207,133 0.29%
Holding current value
$18.7 Million
Previous $14.2 Million 22.52%
% of portfolio
2.69%
Previous 2.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$66.59 - $83.99 $40,353 - $50,897
606 Added 0.29%
207,739 $17.4 Million
Q2 2024

Jul 10, 2024

BUY
$63.15 - $72.88 $91,378 - $105,457
1,447 Added 0.7%
207,133 $14.2 Million
Q1 2024

Apr 11, 2024

BUY
$71.58 - $87.29 $376,582 - $459,232
5,261 Added 2.62%
205,686 $15.1 Million
Q4 2023

Jan 10, 2024

BUY
$73.27 - $83.09 $309,639 - $351,138
4,226 Added 2.15%
200,425 $16.2 Million
Q3 2023

Oct 10, 2023

SELL
$73.94 - $80.67 $24,917 - $27,185
-337 Reduced 0.17%
196,199 $14.7 Million
Q2 2023

Jul 12, 2023

BUY
$76.01 - $86.7 $379,137 - $432,459
4,988 Added 2.6%
196,536 $15.1 Million
Q1 2023

Apr 11, 2023

BUY
$77.31 - $88.08 $227,909 - $259,659
2,948 Added 1.56%
191,548 $15.9 Million
Q4 2022

Jan 12, 2023

BUY
$62.32 - $89.47 $48,048 - $68,981
771 Added 0.41%
188,600 $16.2 Million
Q3 2022

Oct 13, 2022

BUY
$59.54 - $68.01 $531,751 - $607,397
8,931 Added 4.99%
187,829 $11.6 Million
Q2 2022

Jul 15, 2022

BUY
$57.72 - $65.01 $120,230 - $135,415
2,083 Added 1.18%
178,898 $11.1 Million
Q1 2022

Apr 12, 2022

BUY
$57.92 - $72.58 $819,741 - $1.03 Million
14,153 Added 8.7%
176,815 $10.5 Million
Q4 2021

Jan 21, 2022

SELL
$64.88 - $73.64 $10.6 Million - $12 Million
-162,662 Reduced 50.0%
162,662 $11.8 Million
Q4 2021

Jan 12, 2022

BUY
$64.88 - $73.64 $10.8 Million - $12.3 Million
167,172 Added 105.7%
325,324 $23.6 Million
Q3 2021

Oct 12, 2021

BUY
$67.69 - $73.03 $22,879 - $24,684
338 Added 0.21%
158,152 $11 Million
Q2 2021

Jul 13, 2021

BUY
$63.47 - $69.35 $444 - $485
7 Added 0.0%
157,814 $10.9 Million
Q1 2021

Apr 08, 2021

BUY
$60.0 - $68.46 $219,420 - $250,358
3,657 Added 2.37%
157,807 $10.2 Million
Q4 2020

Jan 13, 2021

BUY
$56.65 - $64.55 $195,839 - $223,149
3,457 Added 2.29%
154,150 $8.98 Million
Q3 2020

Oct 07, 2020

SELL
$62.1 - $78.08 $56,511 - $71,052
-910 Reduced 0.6%
150,693 $9.52 Million
Q2 2020

Jul 08, 2020

SELL
$72.34 - $84.0 $234,815 - $272,664
-3,246 Reduced 2.1%
151,603 $11.7 Million
Q1 2020

Apr 08, 2020

SELL
$62.63 - $80.22 $1.2 Million - $1.54 Million
-19,136 Reduced 11.0%
154,849 $11.6 Million
Q4 2019

Jan 08, 2020

SELL
$61.62 - $67.78 $3.21 Million - $3.53 Million
-52,024 Reduced 23.02%
173,985 $11.3 Million
Q3 2019

Oct 03, 2019

SELL
$62.51 - $69.0 $81,700 - $90,183
-1,307 Reduced 0.57%
226,009 $14.3 Million
Q2 2019

Jul 10, 2019

SELL
$61.87 - $69.38 $41,143 - $46,137
-665 Reduced 0.29%
227,316 $15.4 Million
Q1 2019

Apr 11, 2019

SELL
$62.53 - $70.05 $530,567 - $594,374
-8,485 Reduced 3.59%
227,981 $14.8 Million
Q4 2018

Jan 17, 2019

BUY
$60.54 - $79.0 $37,716 - $49,217
623 Added 0.26%
236,466 $14.8 Million
Q3 2018

Oct 02, 2018

SELL
$71.28 - $78.92 $59,162 - $65,503
-830 Reduced 0.35%
235,843 $18.2 Million
Q2 2018

Jul 11, 2018

BUY
$64.88 - $75.68 $286,834 - $334,581
4,421 Added 1.9%
236,673 $16.8 Million
Q1 2018

Apr 19, 2018

BUY
$72.84 - $88.8 $60,238 - $73,437
827 Added 0.36%
232,252 $17.5 Million
Q4 2017

Jan 10, 2018

SELL
$71.15 - $83.52 $82,818 - $97,217
-1,164 Reduced 0.5%
231,425 $16.6 Million
Q3 2017

Oct 11, 2017

BUY
$72.11 - $85.47 $16.8 Million - $19.9 Million
232,589
232,589 $18.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Foundation Resource Management Inc Portfolio

Follow Foundation Resource Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.